Quarterly report pursuant to Section 13 or 15(d)

Condensed Statements of Cash Flows (Unaudited)

v3.22.1
Condensed Statements of Cash Flows (Unaudited) - USD ($)
9 Months Ended
Mar. 31, 2022
Mar. 31, 2021
Cash Flows from Operating Activities    
Net loss $ (6,916,507) $ (9,696,588)
Adjustments to reconcile net loss to net cash and cash equivalents from operating activities:    
Depreciation and amortization 682,068 537,112
Stock compensation expense 1,226,357 650,656
Amortization of debt costs 182,900
Interest expense on notes payable converted to common stock 3,430,931
Value of common stock issued in exchange for consulting services 22,698 789,600
Changes in operating assets and liabilities which used cash:    
Accounts receivable 40,325 54,220
Prepaid expenses and other assets (265,295) (398,412)
Accounts payable 297,621 103,797
Accrued compensation (19,612) 33,871
Deferred revenue (114,010) 164,615
Accrued and other liabilities (42,465) 53,388
Net cash and cash equivalents used in operating activities (5,088,820) (4,093,910)
Cash Flows from Investing Activities    
Purchase of property and equipment (14,267) (67,266)
Investment in capitalized software (574,123) (607,236)
Net cash and cash equivalents used in investing activities (588,390) (674,502)
Cash Flows from Financing Activities – Issuance of common stock – net of issuance costs 3,869,550 12,796,230
Net (Decrease) Increase in Cash and Cash Equivalents (1,807,660) 8,027,818
Cash and Cash Equivalents - Beginning of period 10,713,091 4,093,874
Cash and Cash Equivalents - End of period 8,905,431 12,121,692
Significant Noncash Transactions:    
Acquisition of capitalized software included in accounts payable and accrued liabilities 70,924 94,481
Conversion of convertible notes payable, including accrued interest of $73,315, into 1,127,872 of common stock 2,255,745
Issuance of common stock in exchange for consulting services $ 22,698 $ 789,600